generalized myasthenia gravis
GPTKB entity
Statements (42)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Insurance_Company
|
| gptkbp:affects |
muscle strength
|
| gptkbp:associated_with |
thymoma
thymic hyperplasia |
| gptkbp:caused_by |
autoimmune response
|
| gptkbp:complications |
respiratory failure
myasthenic crisis thymic tumors |
| gptkbp:historical_context |
first described in 1895
named after the Greek word for 'grave muscle weakness' |
| https://www.w3.org/2000/01/rdf-schema#label |
generalized myasthenia gravis
|
| gptkbp:influenced_by |
stress
hormonal changes infections |
| gptkbp:is_characterized_by |
limb weakness
fluctuating muscle weakness bulbar symptoms ocular symptoms respiratory muscle involvement |
| gptkbp:is_often_used_in |
gptkb:philosopher
men younger adults |
| gptkbp:is_popular_in |
1 in 5,000
|
| gptkbp:premiered_on |
any age
|
| gptkbp:research_focus |
gptkb:vaccine
biomarkers genetic factors |
| gptkbp:social_responsibility |
clinical examination
electromyography edrophonium test acetylcholine receptor antibody test anti-Mu SK antibody test |
| gptkbp:symptoms |
fatigue
muscle weakness |
| gptkbp:treatment |
prevent complications
immunosuppressants reduce symptoms anticholinesterase medications thymectomy improve muscle strength |
| gptkbp:bfsParent |
gptkb:Soliris
|
| gptkbp:bfsLayer |
5
|